Respiratory Syncytial Virus (RSV) Diagnostic Testing Market Report: Trends, Insights, and Forecast for 2030

The global Respiratory Syncytial Virus (RSV) Diagnostic Testing Market is projected to reach USD 3.05 billion by 2025 and USD 4.80 billion by 2030, with a CAGR of 6.49% from 2025 to 2030.

Download FREE Sample

Growth is driven by increasing awareness of RSV’s impact across all age groups, particularly beyond infants, and advancements in diagnostic technologies like sensitive, rapid multiplex assays that improve early and accurate detection.

North America leads due to the presence of key players, FDA approvals for combination tests, and the adoption of advanced multiplex diagnostic assays. Industry leaders are focusing on enhancing test speed, sensitivity, and scope to capture greater market share and leverage significant growth opportunities.